510(k) Report

510(k) · Cleared

Cleared

TM eCloud ECG Analysis System

K142349510(k) TraditionalCleared Sep 21, 2015395-day reviewClass II21 CFR 870.1425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Telemed Solutions, Inc. · DQK Computer, Diagnostic, Programmable

Cleared on Sep 21, 2015 as substantially equivalent to K132437 (Ge Medical Systems Information Technologies, Inc., 2013) and 3 other predicates after a 395-day review. Its family tree reaches back 7 generations to 1994.

Decided
Sep 21, 2015
Review
395 days
Class
Class II
Product code
DQK
Recalls
None
Predicates
4

Its longest line of descent runs back 7 generations to K930806 (1994). 30 ancestors in all, the oldest K895208 (1989). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2011: 2 other ancestors2001: 2 other ancestors2009: 1 other ancestor2005: 2 other ancestors2003: 3 other ancestors1998: 5 other ancestors1989: 1 other ancestor1999: 1 other ancestor1996: 1 other ancestor2000: 1 other ancestor1997: 1 other ancestor1995: 2 other ancestors1992: 1 other ancestorK930806 · Zymed Holter Scanner Model 2010 · Agilent Technologies · 1994K955015 · Zymed Holter Scanner Model 2010 · Zymed Medical Instrumentation · 1996K990170 · Holter 2000 · Zymed Medical Instrumentation · 1999K010949 · 2010 Plus Holter for Windows · Agilent Technologies · 2001K051026 · Mars Holter Analysis Workstation · Ge Medical Systems Information Technologies · 2005K093141 · Mars Holter Analysis Workstation · Ge Medical Systems Information Technologies · 2009K132437 · Mars Holter Analysis Workstation · Ge Medical Systems Information Technologies, Inc. · 20131985199019952000200520102015
  1. Root · 7 generations backK930806 Zymed Holter Scanner Model 2010Agilent Technologies · 1994
  2. 6 generations backK955015 Zymed Holter Scanner Model 2010Zymed Medical Instrumentation · 1996
  3. 5 generations backK990170 Holter 2000Zymed Medical Instrumentation · 1999
  4. 4 generations backK010949 2010 Plus Holter for WindowsAgilent Technologies · 2001
  5. 3 generations backK051026 Mars Holter Analysis WorkstationGe Medical Systems Information Technologies · 2005
  6. 2 generations backK093141 Mars Holter Analysis WorkstationGe Medical Systems Information Technologies · 2009
  7. 1 generation backK132437 Mars Holter Analysis WorkstationGe Medical Systems Information Technologies, Inc. · 2013
  8. This deviceK142349 TM eCloud ECG Analysis SystemTelemed Solutions, Inc. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K930806Zymed Holter Scanner Model 2010Agilent Technologies1994—
−6K955015Zymed Holter Scanner Model 2010Zymed Medical Instrumentation1996—
−5K990170Holter 2000Zymed Medical Instrumentation1999—
−4K0109492010 Plus Holter for WindowsAgilent Technologies2001—
−3K051026Mars Holter Analysis WorkstationGe Medical Systems Information Technologies2005—
−2K093141Mars Holter Analysis WorkstationGe Medical Systems Information Technologies2009—
−1K132437Mars Holter Analysis WorkstationGe Medical Systems Information Technologies, Inc.2013—
0 (this device)K142349TM eCloud ECG Analysis SystemTelemed Solutions, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199210
199520
199610
199710
199850
199910
200010
200120
200330
200520
200910
201120
FIG. 1 — Lineage of K142349, 1994–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQK device

  1. #1 K213682 HemoSphere Advanced Monitor, HemoSphere…score 26.6 · 28 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K132437Mars Holter Analysis Workstation
Summary page 5
…gally marketed predicated devices to which equivalence is being claimed is: GE Healthcare. MARS Holter Analysis Workstation K132437 Agilent Technologies 2010 Plus Holter for Windows K003940 Medtronic, Inc.…
Ge Medical Systems Information Technologies, Inc.2013—
*K0039402010 Plus Holter for Windows
Summary page 5
…MARS Holter Analysis Workstation K132437 Agilent Technologies 2010 Plus Holter for Windows K003940 Medtronic, Inc. Paceart OptimaTM System Software K110693 Memtec Corporation…
Agilent Technologies2001—
*K110693Paceart Optima System Software
Summary page 5
…2010 Plus Holter for Windows K003940 Medtronic, Inc. Paceart OptimaTM System Software K110693 Memtec Corporation MobileECG K103427…
Medtronic, Inc.2011—
*K103427Mobileecg System
Summary page 5
…Paceart OptimaTM System Software K110693 Memtec Corporation MobileECG K103427 PAGE 1 of 5 K142349…
Memtec Corp.2011—

Also cleared against K132437: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 5 companies; a new generation was cleared every 3.1 years on median.
  • 2 of the 30 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K132437.

How does its category compare?

All DQK devices

DQK Computer, Diagnostic, Programmable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · DQK

23so far in 2026, the most since 2007

2007: 132008: 42009: 122010: 92011: 122012: 72013: 132014: 92015: 72016: 152017: 72018: 142019: 152020: 162021: 162022: 192023: 212024: 132025: 222026 (partial year): 23
2007high 23 (2026) · low 4 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQK

95in 2025

2007: 83 days median2008: 70 days median2009: 93 days median2010: 64 days median2011: 69 days median2012: 74 days median2013: 68 days median2014: 90 days median2015: 125 days median2016: 190 days median2017: 146 days median2018: 150 days median2019: 113 days median2020: 123 days median2021: 132 days median2022: 136 days median2023: 133 days median2024: 100 days median2025: 95 days median2026 (partial year): 151 days median
2007high 190 (2016) · low 64 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQK

1in 2025

2007: 42008: 12009: 22010: 32011: 22012: 32013: 12014: 42015: 22017: 22018: 62019: 12020: 12021: 12022: 22023: 22024: 242025: 12026 (partial year): 2
2007high 24 (2024) · low 0 (2016)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DQK

433in 2025

2007: 182008: 342009: 402010: 492011: 552012: 1292013: 1802014: 1152015: 1312016: 3402017: 2522018: 2612019: 2182020: 2152021: 3512022: 3192023: 3402024: 5572025: 433
2007high 557 (2024) · low 18 (2007)2025

MAUDE reports naming product code DQK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071383418
2008470134
20091293240
2010964349
20111269255
20127743129
201313681180
20149904115
201571252131
2016151900340
201771462252
2018141506261
2019151131218
2020161231215
2021161321351
2022191362319
2023211332340
20241310024557
202522951433
2026231512—

What is it indicated for?

The TM eCloud ECG Analysis System, using proprietary algorithm, is intended for use in adults and children of any age from birth upwards. The Program makes significant use of the patient’s age and gender and will provide a unique diagnosis if age differs only by a few days in the case of neonates. It is a program that is based on normal limits derived using the algorithm itself with this applying to criteria for subjects of all ages, including neonates.…

Read the full statement (334 words)

The TM eCloud ECG Analysis System, using proprietary algorithm, is intended for use in adults and children of any age from birth upwards. The Program makes significant use of the patient’s age and gender and will provide a unique diagnosis if age differs only by a few days in the case of neonates. It is a program that is based on normal limits derived using the algorithm itself with this applying to criteria for subjects of all ages, including neonates.

TM eCloud ECG Analysis System is qualified to evaluate, detect, and aid in the physician diagnosis of the following cardiac arrhythmias and/or conduction defects:

• Evaluation of symptoms that may be caused by cardiac arrhythmia and /or conduction disturbances

• Evaluation of symptoms that may be due to myocardial ischemia

• Detection of ECG events that alter prognosis in certain forms of heart disease

• Detection and analysis of indirect pacemaker function and failure

• Determination of cardiac response to lifestyle

• Evaluation of therapeutic interventions

• Investigations in epidemiology and clinical trials

• Evaluation of heart rate variability in the assessment of heart disease

TM eCloud ECG Analysis System is intended to provide an interpretation of up to 12-channel ECG in all situations including resting and ambulatory ECG including Holter, cardiac event, and mobile cardiac telemetry. This software qualifies to be used in hospitals, physician offices, and scanning services. It is designed for acquisition, analysis, edit, review, report and storage of all ECG and multi-parameter data. It is capable of diagnosing all commonly recognized ECG abnormalities such as myocardial infarction (MI), acute MI, ventricular hypertrophy, abnormal ST-T changes, lethal arrhythmias, and common rhythm abnormalities.

TM eCloud ECG Analysis System can analyze recordings performed on newborns, children, and adults.

TM eCloud ECG Analysis System’s interpretation results are not intended to be the sole means of diagnosis for any abnormal ECG that may be detected. It is offered to physicians and clinicians on an advisory basis only in conjunction with the physician’s knowledge of ECG.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K142349: TM eCloud ECG Analysis System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K142349

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026